Literature DB >> 7490479

Phenotypic and functional heterogeneity among murine epidermal-derived dendritic cell clones.

S Xu1, P R Bergstresser, A Takashima.   

Abstract

We have established recently long-term dendritic cell lines from the epidermis of newborn BALB/c mice. These lines, termed XS series, resembled epidermal resident Langerhans cells or their progenitors in terms of surface phenotype, antigen-presenting capacity, and growth factor requirement. We examined in this study the degree of clonal heterogeneity among XS cells with respect to each of these features. Twelve stable clones were established by limiting dilution microculture from 8-10-week-old cultures of the XS52 or XS20 line. Despite the uniform expression of CD45, these clones varied substantially in their expression of Ia, B7-1, and B7-2 molecules. They also varied significantly in their relative efficiency in activating T cells. Finally, remarkable clone-to-clone heterogeneity was also observed in their growth factor responsiveness; some clones responded equally well to granulocyte macrophage-colony-stimulating factor-1, whereas others responded preferentially to one or the other of these factors. We propose that the observed clonal heterogeneity in XS cells reflects possible heterogeneity in the state of maturation and mitotic potential among the starting populations, i.e., skin-associated dendritic cells in newborn mice.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7490479     DOI: 10.1111/1523-1747.ep12326625

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  8 in total

1.  CD4 T cell-induced, bid-dependent apoptosis of cutaneous dendritic cells regulates T cell expansion and immune responses.

Authors:  Sanjay Pradhan; Joseph Genebriera; Warren L Denning; Kumar Felix; Craig A Elmets; Laura Timares
Journal:  J Immunol       Date:  2006-11-01       Impact factor: 5.422

2.  Quantitative analysis of the immunopotency of genetically transfected dendritic cells.

Authors:  L Timares; A Takashima; S A Johnston
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-27       Impact factor: 11.205

3.  Immunoprevention of chemical carcinogenesis through early recognition of oncogene mutations.

Authors:  Tahseen H Nasti; Kyle J Rudemiller; J Barry Cochran; Hee Kyung Kim; Yuko Tsuruta; Naomi S Fineberg; Mohammad Athar; Craig A Elmets; Laura Timares
Journal:  J Immunol       Date:  2015-02-18       Impact factor: 5.422

4.  Vaccinia virus infection attenuates innate immune responses and antigen presentation by epidermal dendritic cells.

Authors:  Liang Deng; Peihong Dai; Wanhong Ding; Richard D Granstein; Stewart Shuman
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

5.  Hepatitis C virus structural proteins impair dendritic cell maturation and inhibit in vivo induction of cellular immune responses.

Authors:  Pablo Sarobe; Juan José Lasarte; Aintzane Zabaleta; Laura Arribillaga; Ainhoa Arina; Ignacio Melero; Francisco Borrás-Cuesta; Jesús Prieto
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

6.  Role of the parasite-derived prostaglandin D2 in the inhibition of epidermal Langerhans cell migration during schistosomiasis infection.

Authors:  V Angeli; C Faveeuw; O Roye; J Fontaine; E Teissier; A Capron; I Wolowczuk; M Capron; F Trottein
Journal:  J Exp Med       Date:  2001-05-21       Impact factor: 14.307

7.  Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity.

Authors:  W Song; H L Kong; H Carpenter; H Torii; R Granstein; S Rafii; M A Moore; R G Crystal
Journal:  J Exp Med       Date:  1997-10-20       Impact factor: 14.307

8.  Differentially Tolerized Mouse Antigen Presenting Cells Share a Common miRNA Signature Including Enhanced mmu-miR-223-3p Expression Which Is Sufficient to Imprint a Protolerogenic State.

Authors:  Matthias Bros; Mahmoud Youns; Verena Kollek; Diana Buchmüller; Franziska Bollmann; Ean-Jeong Seo; Jonathan Schupp; Evelyn Montermann; Svetlana Usanova; Hartmut Kleinert; Thomas Efferth; Angelika B Reske-Kunz
Journal:  Front Pharmacol       Date:  2018-08-17       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.